NCT00433043View on ClinicalTrials.gov

BOAT: Beta Blocker Uptitration With OptiVol After Cardiac Resynchronization Therapy (CRT)

PHASE4TerminatedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

May 31, 2009

Study Completion Date

May 31, 2009

Conditions
Congestive Heart Failure
Interventions
DRUG

Beta blocker (carvedilol or metoprolol succinate)

Both groups get CRT. Group 1 is uptitrated to target dose beta blocker after CRT. Group 2 maintains their b-blocker dose from study entry.

PROCEDURE

CRT (cardiac resynchronization therapy)

Both arms

Trial Locations (3)

10019

St. Lukes Roosevelt Hospital, New York

14642

University of Rochester, Rochester

19107

Jefferson Medical College, Philadelphia

Sponsors

Collaborators (1)

Medtronic
All Listed Sponsors
collaborator

Medtronic

INDUSTRY

lead

St. Luke's-Roosevelt Hospital Center

OTHER

NCT00433043 - BOAT: Beta Blocker Uptitration With OptiVol After Cardiac Resynchronization Therapy (CRT) | Biotech Hunter | Biotech Hunter